Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report

2008 ◽  
Vol 12 (2) ◽  
pp. 155-158 ◽  
Author(s):  
Takeo Kosaka ◽  
Shuji Mikami ◽  
Akira Miyajima ◽  
Mototsugu Oya
2013 ◽  
Vol 1 (2) ◽  
pp. 318-320 ◽  
Author(s):  
ZHENYU FU ◽  
LIGUO SUN ◽  
YUHUA HUANG ◽  
JIE ZHANG ◽  
ZICHAO ZHANG ◽  
...  

2016 ◽  
Vol 14 (1) ◽  
Author(s):  
D. G. V. D. Seneth Gajasinghe ◽  
Ishra Nazeer ◽  
Hansika P. Maddumage ◽  
Chrysantha Perera ◽  
Anuruddha M. Abeygunasekera

2019 ◽  
Vol 17 (1) ◽  
pp. 70-73
Author(s):  
Sol Yoon ◽  
Jae Hwi Choi ◽  
Sin Woo Lee ◽  
Seong Uk Jeh ◽  
Jeong Seok Hwa ◽  
...  

Urology ◽  
2019 ◽  
Vol 123 ◽  
pp. e1-e3
Author(s):  
Youjian Li ◽  
Xuefeng Qiu ◽  
Weijian Li ◽  
Yang Yang ◽  
Rong Yang ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Facundo Davaro ◽  
Elizabeth Davaro ◽  
Amna Qureshi ◽  
Lindsay Lombardo

Renal cell carcinoma (RCC) is associated with a variety of different histopathologic subtypes in which each subtype may be further subclassified. These entities carry with them unique prognoses and necessitate treatment with specific immunotherapy agents should advanced disease be uncovered. Meanwhile, aberrant physiologic processes may lead to unique histologic findings within these subtypes, further complicating management and prognostication. Heterotopic ossification within RCC is one of these rare occurrences and was once thought to have favorable prognostic implications. We report a case of a young female with papillary type 2 RCC with heterotopic ossification.


Cancer Cell ◽  
2011 ◽  
Vol 20 (4) ◽  
pp. 511-523 ◽  
Author(s):  
Aikseng Ooi ◽  
Jing-Chii Wong ◽  
David Petillo ◽  
Douglas Roossien ◽  
Victoria Perrier-Trudova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document